HC (n= 30) M ± S.D. | BPD (n= 29) M ± S.D. | ADHD (n= 28) M ± S.D. | F/χ 2 | p | η p 2 /φ c | |
---|---|---|---|---|---|---|
Age | 27.53 ± 6.60 | 27.07 ± 6.51 | 30.11 ± 7.96 | 1.70 | .189 | |
Intelligence (IQ) | ||||||
Raven SPM | 111.70 ± 10.50 | 107.07 ± 12.32 | 105.46 ± 12.71 | 2.18 | .119 | |
Income, n (%) | ||||||
100-300€ | 7 (23) | 8 (28) | 6 (21) | |||
350-500€ | 6 (20) | 3 (10) | 4 (14) | 3.00 | .934 | |
550-700€ | 7 (23) | 6 (21) | 4 (14) | |||
750-1000€ | 3 (10) | 3 (10) | 3 (11) | |||
+ 1000€ | 7 (23) | 9 (31) | 11 (39) | |||
Years of education, n (%) | ||||||
Less than 9 years | 0 (0) | 0 (0) | 4 (14) | |||
9 years | 0 (0) | 1 (3) | 3 (11) | 15.60 | .016b | .30 |
10 years | 8 (27) | 9 (31) | 10 (36) | |||
13 years | 22 (73) | 19 (66) | 11 (39) | |||
Current co-morbidities, n (%) | ||||||
MDD | 4 (14) | 1 (4) | ||||
Anxiety disorder | 11 (38) | 5 (18) | ||||
Substance abuse | 0 (0) | 0 (0) | ||||
Eating disorder | 8 (28) | 3 (11) | ||||
PTSD | 13 (45) | 1 (4) | ||||
OCD | 3 (10) | 0 (0) | ||||
Medication, n (%) d | ||||||
No stable medication | 30 (100) | 23 (88) | 25 (89) | |||
Intake stopped 2 week prior to the study | 0 (0) | 3 (12) | 3 (11) | |||
WURS-k | 6.67 ± 5.71 | 29.62 ± 16.40 | 40.29 ± 13.83 | 53.11 | ≤.001a,b,c | .56 |
ADHD-RS | 6.53 ± 5.45 | 19.93 ± 8.68 | 34.25 ± 7.65 | 102.64 | ≤.001a,b,c | .71 |
CAARS | 31.10 ± 17.59 | 89.66 ± 26.10 | 121.18 ± 23.58 | 118.91 | ≤.001a,b,c | .74 |
BSL23 | 2.60 ± 4.12 | 47.90 ± 20.54 | 17.18 ± 11.89 | 81.74 | ≤.001a,b,c | .66 |
BDI-II | 2.17 ± 3.26 | 32.00 ± 11.55 | 16.46 ± 11.35 | 73.30 | ≤.001a,b,c | .64 |
BIS-11 | 53.40 ± 7.43 | 66.45 ± 10.49 | 81.29 ± 10.42 | 62.16 | ≤.001a,b,c | .60 |
DERS | 145.00 ± 12.92 | 85.14 ± 19.31 | 103.18 ± 19.59 | 91.31 | ≤.001a,b,c | .69 |